Environmental factors associated with nosocomial legionellosis after anti-tumor necrosis factor therapy: Case study

被引:4
作者
Boivin, Sandra [1 ]
Lacombe, Marie-Claude [1 ]
Lalancette, Linda [2 ]
Allard, Andre [1 ]
Bordeleau, Michel [2 ]
Laverdure, Guy [1 ]
机构
[1] Laurentian Reg Hlth & Social Agcy, St Jerome, PQ J7Z 5N6, Canada
[2] St Eustache Hosp, St Eustache, PQ, Canada
关键词
Tumor necrosis factor; Remicade; Infliximab; Legionella; Construction; Infection prevention; TNF-ALPHA THERAPY; RHEUMATOID-ARTHRITIS; PNEUMOPHILA PNEUMONIA; LEGIONNAIRES-DISEASE; PATIENT; INFLIXIMAB; CONTAMINATION; INFECTIONS; SYSTEMS; RISK;
D O I
10.1016/j.ajic.2011.05.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In response to 2 reported cases of nosocomial legionellosis after anti-tumor necrosis factor (TNF) treatment, the environmental controls and testing facilities in a 221-bed acute care hospital were investigated. This investigation led to the implementation of a series of specific preventive measures adapted from protocols used to protect immunosuppressed patients. These 2 cases of legionellosis might be related to 2 concurrent events: treatment of hospitalized patients with anti-TNF drugs and secondary environmental changes related to major construction work. Patients undergoing anti-TNF treatment may be at increased risk for developing opportunistic infections during construction work, renovations, or water supply perturbations and require specific preventive measures. Crown Copyright (C) 2012 Published by Elsevier Inc. on behalf of the Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.
引用
收藏
页码:470 / 473
页数:4
相关论文
共 41 条
  • [1] Abbas Z, 2003, CANADA COMMUNICABLE
  • [2] FACTORS CONTRIBUTING TO THE CONTAMINATION OF HOSPITAL WATER DISTRIBUTION-SYSTEMS BY LEGIONELLAE
    ALARY, M
    JOLY, JR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) : 565 - 569
  • [3] Legionellosis in patient treated with infliximab
    Albert, C
    Vandenbos, F
    Brocq, O
    Carles, D
    Euller-Ziegler, L
    [J]. REVUE DE MEDECINE INTERNE, 2004, 25 (02): : 167 - 168
  • [4] Alfandari S, 2006, PREVENTION HOSP BORN
  • [5] Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1
  • [6] [Anonymous], RECOMM REP
  • [7] Baumard S, 2006, REV RHUM, V73, P1163
  • [8] Severe Legionella pneumophila Pneumonia Following Infliximab Therapy in a Patient with Crohn's Disease
    Beigel, Florian
    Juergens, Matthias
    Filik, Levent
    Bader, Lutz
    Lueck, Christian
    Goeke, Burkhard
    Ochsenkuehn, Thomas
    Brand, Stephan
    Seiderer, Julia
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) : 1240 - 1244
  • [9] Bobbio-Pallavicini F, 2008, REACTIONS, V1209, P6
  • [10] Infliximab for patients with refractory ulcerative colitis
    Chey, WY
    [J]. INFLAMMATORY BOWEL DISEASES, 2001, 7 : S30 - S33